Seek Returns

ABBV vs. KO: AbbVie vs. Coca-Cola Stock Comparison

How do AbbVie (ABBV) and Coca-Cola (KO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Coca-Cola (KO) belongs to Consumer Staples (Food, Beverage & Tobacco) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Coca-Cola (KO)
Profile ItemABBVKO
NameAbbVie Inc.The Coca-Cola Company
Country/RegionUnited StatesUnited States
GICS SectorHealth CareConsumer Staples
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesFood, Beverage & Tobacco
GICS IndustryBiotechnologyBeverages
GICS Sub-IndustryBiotechnologySoft Drinks & Non-alcoholic Beverages
Market Capitalization514.92 billion USD411.56 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJanuary 2, 2013January 2, 1962
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ABBV
KO
GSPC
Loading price history…
AbbVie (ABBV) vs. Coca-Cola (KO), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and Coca-Cola (KO). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and Coca-Cola (KO). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Total Return (1Y)37.33%39.33%
Total Return (3Y, Annualized)32.74%22.59%
Total Return (5Y, Annualized)24.73%14.43%

Risk Profile

Drawdown History

ABBV
KO
GSPC
Loading price history…
AbbVie (ABBV) vs. Coca-Cola (KO), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and Coca-Cola (KO). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Volatility (1Y, Annualized)25.65%18.90%
Beta (5Y)0.210.27
Max Drawdown (5Y)-21.92%-17.27%
Avg. Volume (3M)4.76M16.05M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and KO are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Sharpe Ratio (1Y)1.291.85
Sortino Ratio (1Y)2.023.17

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Coca-Cola (KO) earns 40.59% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

KO

Food, Beverage & Tobacco industry group

40.59%

KO
40.59%
Max
32.02%
Q3
16.61%
Median
10.05%
Q1
4.10%
Min
-10.50%
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): ABBV does not report ROE, so it has no value marker; KO is benchmarked against the Food, Beverage & Tobacco industry group.

Net Margin (TTM)

Coca-Cola (KO) at 28.65% keeps the most of each sales dollar — above its industry’s net margin range — and AbbVie (ABBV) at 15.67% also retains a top-quartile share.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

KO

Food, Beverage & Tobacco industry group

28.65%

KO
28.65%
Max
24.83%
Q3
11.22%
Median
5.94%
Q1
2.05%
Min
-11.49%
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Operating Margin (TTM)

Both AbbVie (ABBV) at 39.59% and Coca-Cola (KO) at 33.36% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

KO

Food, Beverage & Tobacco industry group

33.36%

Max
34.91%
KO
33.36%
Q3
17.57%
Median
11.06%
Q1
4.15%
Min
-15.06%
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
ROE (TTM)--40.59%
ROA (TTM)10.74%9.59%
Net Margin (TTM)15.67%28.65%
Operating Margin (TTM)39.59%33.36%
Gross Margin (TTM)73.72%62.32%

Growth

Revenue Growth

Both AbbVie (ABBV) at 8.57% and Coca-Cola (KO) at 1.87% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their Revenue Growth across different time periods.

EPS Growth

Coca-Cola (KO) at 23.58% sits in the top EPS growth quartile, while AbbVie (ABBV) at -0.84% is closer to the peer norm — faster per-share earnings growth for KO.

Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Revenue Growth (YoY)8.57%1.87%
Revenue Growth (3Y CAGR)1.75%3.69%
EPS Growth (YoY)-0.84%23.58%
EPS Growth (3Y CAGR)-29.03%11.55%

Financial Strength

Current Ratio (MRQ)

Coca-Cola (KO) at 1.38 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

KO

Food, Beverage & Tobacco industry group

1.38

Max
4.01
Q3
2.35
Median
1.53
KO
1.38
Q1
1.02
Min
0.33
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Coca-Cola (KO) carries debt-to-equity ratio of 1.07 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

KO

Food, Beverage & Tobacco industry group

1.07

Max
2.19
Q3
1.11
KO
1.07
Median
0.68
Q1
0.33
Min
0.00
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): ABBV does not report debt-to-equity ratio, so it has no value marker; KO is benchmarked against the Food, Beverage & Tobacco industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Current Ratio (MRQ)0.871.38
Debt / Equity (MRQ)--1.07
Net Debt / EBITDA2.211.48

Dividends

Dividend Yield (TTM)

Coca-Cola (KO) at 2.19% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

KO

Food, Beverage & Tobacco industry group

2.19%

Max
9.38%
Q3
3.77%
KO
2.19%
Median
1.76%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Coca-Cola (KO) reports 61.95%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

KO

Food, Beverage & Tobacco industry group

61.95%

Max
199.19%
Q3
81.03%
KO
61.95%
Median
41.52%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
Dividend Yield (TTM)2.40%2.19%
Dividend Payout Ratio (TTM)117.35%61.95%

Valuation

P/E Ratio (TTM)

Coca-Cola (KO) at 28.22 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

KO

Food, Beverage & Tobacco industry group

28.22

Max
52.52
Q3
30.78
KO
28.22
Median
18.76
Q1
12.77
Min
4.72
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 prices around its industry’s typical P/S ratio, while Coca-Cola (KO) at 8.06 clears its benchmark range — KO looks notably rich on sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

KO

Food, Beverage & Tobacco industry group

8.06

KO
8.06
Max
4.64
Q3
2.27
Median
1.17
Q1
0.52
Min
0.00
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Coca-Cola (KO) reports 11.01, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

KO

Food, Beverage & Tobacco industry group

11.01

KO
11.01
Max
6.35
Q3
3.07
Median
1.58
Q1
0.82
Min
0.00
Loading chart…
AbbVie (ABBV) vs. Coca-Cola (KO): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Food, Beverage & Tobacco industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Coca-Cola (KO)
MetricABBVKO
P/E Ratio (TTM)50.0528.22
P/S Ratio (TTM)7.808.06
P/B Ratio (MRQ)-112.3411.01
Free Cash Flow Yield (TTM)3.44%1.06%